Researchers will begin recruiting cancer survivors who completed treatments at least six months earlier but are still experiencing moderate to severe levels of cancer-related fatigue for an open-label placebo trial. Ted Kaptchuk, professor of medicine at Beth Israel Deaconess Medical Center, is a coleader of the research.
